Literature DB >> 21807209

Advancement in optimization tactic achieved by newly developed chromatographic response function: application to LC separation of raloxifene and its impurities.

B Jančić-Stojanović1, T Rakić, N Kostić, A Vemić, A Malenović, D Ivanović, M Medenica.   

Abstract

In this paper a new chromatographic response function (CRF) is designed and proposed for utilization in the optimization strategies. The function capability to represent the overall quality of a experimentally obtained chromatograms was compared to the other two objective functions and proved to give more accurate and reliable results. The new CRF has improved concept of separation and time term estimation. It reflects all important defects of the chromatogram such as the appearance of asymmetrical or overlapping peaks and prolonged elution time and allows the appropriate weighting of each of them. The LC separation of raloxifene and its four impurities was evaluated through the central composite design experimental plan choosing the new CRF to be the only output of the system. The function demonstrated the ability to judge the impact of the complex interactions of the selected chromatographic parameters (acetonitrile content in the mobile phase, sodium dodecyl sulfate concentration in the water phase, pH of the mobile phase and column temperature) on the mixture behavior and led to the determination of the optimal separation conditions. The newly developed CRF proved to have the advanced performances and it presents the important step forward in the optimization of the chromatographic separation.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21807209     DOI: 10.1016/j.talanta.2011.06.029

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  1 in total

1.  Systematical approach in evaluation of LC method for determination of raloxifene hydrochloride and its impurities employing experimental design.

Authors:  B Jančić Stojanović; T Rakić; B Slavković; N Kostić; A Vemić; A Malenović
Journal:  J Pharm Anal       Date:  2012-10-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.